Cytochrome P450 in the Brain ; A Review
Journal:
Current Drug Metabolism
Volume:
2
Page:
245-263
Author(s):
E. Hedlund, J. A. Gustafsson and M. Warner
The Hereditary Disease Array Group (HDAG) - Microarrays, Models and Mechanisms : A Collaboration Update
Journal:
Current Genomics
Volume:
2
Page:
221-229
Author(s):
Tim- Rasmus Kiehl, James M. Olson and Stefan M. Pulst
NMDA Receptor Pharmacology: Perspectives from Molecular Biology
Journal:
Current Drug Targets
Volume:
2
Page:
215-231
Author(s):
David R. Lynch and Rodney P. Guttmann
Ifenprodil, a Novel NMDA Receptor Antagonist : Site and Mechanism of Action
Journal:
Current Drug Targets
Volume:
2
Page:
285-298
Author(s):
Keith Williams
Convergence of PKC-Dependent Kinase Signal Cascades on NMDA Receptors
Journal:
Current Drug Targets
Volume:
2
Page:
299-312
Author(s):
J. F. Macdonald, S. A. Kotecha, W. Y. Lu and M. F. Jackson
The Use of Antibody Engineering to Create Novel Drugs that Target N-methyl-D-Aspartate Receptors
Journal:
Current Drug Targets
Volume:
2
Page:
331-345
Author(s):
Joseph R. Moskal, Hirotaka Yamamoto and Patricia A. Colley
Infective Proteins: The Prion Puzzle
Journal:
Current Protein & Peptide Science
Volume:
2
Page:
191-204
Author(s):
Fabrizio Ceciliani and Paola Pergami
Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
171-199
Author(s):
Zafar H. israili
Changes in Immune and Endocrine Systems in Scrapie-Infected Animals
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
171-183
Author(s):
X. Ye, A. C. Scallet and R. I. Carp
Rate Limiting Steps of AAV Transduction and Implications for Human Gene Therapy
Journal:
Current Gene Therapy
Volume:
1
Page:
137-147
Author(s):
S. Sanlioglu, M. M. Monick, G. Luleci, G. W. Hunninghake and J. F. Engelhardt